India’s CDSCO Issues Order Clarifying Requirements for Clinical Trial Applications

Drug Industry Daily
A A
Indian regulators are reminding drug investigators seeking approval for clinical trials that they must submit information on the unmet medical need and risk-benefit assessments of the proposed drug, as well as comparisons of the innovator product to existing options.

To View This Article:

Login

Subscribe To Drug Industry Daily